These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32851454)
1. The impact of selected risk factors among breast cancer molecular subtypes: a case-only study. Pizzato M; Carioli G; Rosso S; Zanetti R; La Vecchia C Breast Cancer Res Treat; 2020 Nov; 184(1):213-220. PubMed ID: 32851454 [TBL] [Abstract][Full Text] [Related]
2. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program. Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999 [TBL] [Abstract][Full Text] [Related]
3. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357 [TBL] [Abstract][Full Text] [Related]
4. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Xing P; Li J; Jin F Med Oncol; 2010 Sep; 27(3):926-31. PubMed ID: 19771534 [TBL] [Abstract][Full Text] [Related]
5. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Brouckaert O; Rudolph A; Laenen A; Keeman R; Bolla MK; Wang Q; Soubry A; Wildiers H; Andrulis IL; Arndt V; Beckmann MW; Benitez J; Blomqvist C; Bojesen SE; Brauch H; Brennan P; Brenner H; Chenevix-Trench G; Choi JY; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Eriksson M; Fasching PA; Figueroa J; Flyger H; Giles GG; González-Neira A; Guénel P; Hall P; Hollestelle A; Hopper JL; Ito H; Jones M; Kang D; ; Knight JA; Kosma VM; Li J; Lindblom A; Lilyquist J; Lophatananon A; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Muir K; Nevanlinna H; Peterlongo P; Pylkäs K; Saajrang S; Seynaeve C; Shen CY; Shu XO; Southey MC; Swerdlow A; Teo SH; Tollenaar RAEM; Truong T; Tseng CC; van den Broek AJ; van Deurzen CHM; Winqvist R; Wu AH; Yip CH; Yu JC; Zheng W; Milne RL; Pharoah PDP; Easton DF; Schmidt MK; Garcia-Closas M; Chang-Claude J; Lambrechts D; Neven P Breast Cancer Res; 2017 Nov; 19(1):119. PubMed ID: 29116004 [TBL] [Abstract][Full Text] [Related]
6. Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. Gaudet MM; Gierach GL; Carter BD; Luo J; Milne RL; Weiderpass E; Giles GG; Tamimi RM; Eliassen AH; Rosner B; Wolk A; Adami HO; Margolis KL; Gapstur SM; Garcia-Closas M; Brinton LA Cancer Res; 2018 Oct; 78(20):6011-6021. PubMed ID: 30185547 [TBL] [Abstract][Full Text] [Related]
7. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186 [TBL] [Abstract][Full Text] [Related]
8. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI Cancer Causes Control; 2011 Mar; 22(3):399-405. PubMed ID: 21184265 [TBL] [Abstract][Full Text] [Related]
9. Analysis of breast cancer subtypes and their correlations with receptors and ultrasound. Sechel G; Rogozea LM; Roman NA; Ciurescu D; Cocuz ME; Manea RM Rom J Morphol Embryol; 2021; 62(1):269-278. PubMed ID: 34609431 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Parise CA; Bauer KR; Brown MM; Caggiano V Breast J; 2009; 15(6):593-602. PubMed ID: 19764994 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya. Sayed S; Fan S; Moloo Z; Wasike R; Bird P; Saleh M; Shaikh AJ; Figueroa JD; Naidoo R; Makokha FW; Gardner K; Oigara R; Njoroge FW; Magangane P; Mutebi M; Chauhan R; Mwanzi S; Govender D; Yang XR Breast Cancer Res; 2021 Jun; 23(1):68. PubMed ID: 34174935 [TBL] [Abstract][Full Text] [Related]
13. Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study. Chitkara A; Mesa-Eguiagaray I; Wild SH; Hall PS; Cameron DA; Sims AH; Figueroa JD Breast Cancer Res Treat; 2022 Nov; 196(2):379-387. PubMed ID: 36116093 [TBL] [Abstract][Full Text] [Related]
14. The Impact of Reproductive Factors on the Risk of Breast Cancer by ER/PR and HER2: A Multicenter Case-Control Study in Northern and Eastern China. Xie F; Liu L; Yang H; Liu M; Wang S; Guo J; Yu L; Zhou F; Wang F; Xiang Y; Yu Z; Wang S Oncologist; 2022 Feb; 27(1):e1-e8. PubMed ID: 35305101 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery. Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768 [TBL] [Abstract][Full Text] [Related]
16. Correlation between Ki67 and histological grade in breast cancer patients treated with preoperative chemotherapy. Petric M; Martinez S; Acevedo F; Oddo D; Artigas R; Camus M; Sanchez C Asian Pac J Cancer Prev; 2014; 15(23):10277-80. PubMed ID: 25556461 [TBL] [Abstract][Full Text] [Related]
17. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906 [TBL] [Abstract][Full Text] [Related]
18. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women. Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of prolactin receptor expression in breast cancer subtypes]. Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231 [TBL] [Abstract][Full Text] [Related]
20. Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes. Kleinstern G; Scott CG; Tamimi RM; Jensen MR; Pankratz VS; Bertrand KA; Norman AD; Visscher DW; Couch FJ; Brandt K; Shepherd J; Wu FF; Chen YY; Cummings SR; Winham S; Kerlikowske K; Vachon CM Breast Cancer Res Treat; 2021 May; 187(1):215-224. PubMed ID: 33392844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]